94
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Host-Microbe Interaction in HLA-B27-associated Diseases

Pages 153-157 | Published online: 08 Jul 2009

References

  • Dougados M, van der Linden S, Juhlln R, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991; 34: 1218–27
  • Brewerton D A, Hart F D, Nicholls A, Caffrey M, James D C, Sturrock R D. Ankylosing spondylitis and HL-A 27. Lancet 1973; 1: 904–7
  • Schlosstein L, Terasaki P I, Bluestone R, Person C M. High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med 1973; 288: 704–6
  • Ahvonen P, Sievers K, Aho K. Arthritis associated with Yersinia enterocolitica infection. Acta Rheum Scand 1969; 15: 232–53
  • Grantors K. Do bacterial antigens cause reactive arthritis?. Rheum Dis Clin North Am 1992; 18: 37–48
  • Aho K, Ahvonen P, Lassus A, Sievers K, Tiilikainen A. HLA-B27 in reactive arthritis. A study of Yersinia arthritis and Reiter's disease. Arthritis Rheum 1974; 17: 521–6
  • Leirisalo M, Skylv G, Kousa M, et al. Follow-up study of patients with Reiter's disease and reactive arthritis with special reference to HLA-B27. Arthritis Rheum 1982; 25: 249–59
  • Inman R D, Scofield R H. Etiopathogenesis of ankylosing spondylitis and reactive arthritis. Curr Opin Rheumatol 1994; 6: 360–70
  • Sieper J, Braun J. Pathogenesis of spondylarthropathies. Persistent bacterial antigen, autoimmunity, or both?. Arthritis Rheum 1995; 38: 1547–54
  • Burmester G R, Kamradt T, Krause A, Mitchison N A, Sieper J, Wolf N. Immunology of reactive arthritides. Annu Rev Immunol 1995; 13: 229–50
  • Feltkamp T EW, Khan M, Lopez de Castro J A. The pathogenetic role of HLA-B27. Immunol Today 1996; 17: 5–7
  • Maki-Lkola O, Granfors K. Salmonella-triggered reactive arthritis. Lancet 1992; 339: 1096–8
  • Braun J, Laitko S, Treharne J, et al. Chlamydia pneumoniae - a new causative agent of reactive arthritis and undifferentiated oligoarthritis. Ann Rheum Dis 1994; 53: 100–5
  • Grantors K, Ogasawara M, Hill J L, et al. Analysis of IgA anti-lipopolysaccharide antibodies in yers/n/a-triggered reactive arthritis. J Infect Dis 1989; 159: 1142–7
  • Grantors K, Jalkanen S, von Essen R, et al. Yersinia antigens in synovial fluid cells from patients with reactive arthritis. N Engl J Med 1989; 320: 216–21
  • Granfors K, Jalkanen S, Lindberg A A, et al. Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis. Lancet 1990; 335: 685–8
  • Grantors K, Jalkanen S, Toivanen P, Koski J, Lindberg A A. Bacterial lipopolysaccharide in synovial fluid cells in Shigella triggered reactive arthritis. J Rheumatol 1992; 19: 500
  • Granfors K, Toivanen A. IgA-anti-Vere/n/a antibodies in Yersinia triggered reactive arthritis. Ann Rheum Dis 1986; 45: 561–5
  • Ebringer A. Ankylosing spondylitis is caused by Klebsiella: evidence from immunogenetic, microbiologic, and serologic studies. Rheum Dis Clin North Am 1992; 18: 105–21
  • Ebringer R W, Cawdell D R, Cowling P, Ebringer A. Sequential studies in ankylosing spondylitis. Association of Klebsiella pneumoniae with active disease. Ann Rheum Dis 1978; 37: 16–151
  • Trull A, Ebringer A, Panayi G, Ebringer R, James D C. HLA-B27 and the immune response to enterobacterial antigens in ankylosing spondylitis. Clin Exp Immunol 1984; 55: 74–80
  • Maki-Lkola O, Nissila M, Lehtinen K, Leirisalo-Repo M, Toivanen P, Granfors K. Antibodies to Klebsiella pneumoniae, Escherichia coli and Proteus mirabilis in the sera of patients with axial and peripheral form of ankylosing spondylitis. Br J Rheumatol 1995; 34: 413–7
  • Sahly H, Podschun R, Sass R, Broker B, Kekow J, Gross W L. Serum antibodies to Klebsiella capsular polysaccharides in ankylosing spondylitis. Arthritis Rheum 1994; 37: 754–9
  • Nissila M, Lahesmaa R, Leirisalo-Repo M, Lehtinen K, Toivanen P, Granfors K. Antibodies to Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis in AS: effect of sulfasalazine treatment. J Rheumatol 1994; 21: 2082–7
  • Finlay B B, Falkow S. Salmonella as an intracellular parasite. Mol Microbiol 1989; 3: 1833–41
  • Pierson D E. Mechanisms of Yersinia entry into mammalian cells. Molecular Genetics of Bacterial Pathogenesis, V L Miller, J B Kaper, D A Portnoy, R R Isberg. ASM Press, Washington, DC 1994; 235–48
  • Grlpenberg-Lerche C, Skurnlk M, Zhang L, Söderström K-O, Tolvanen P. Role of YadA in arthritogenicity of Yersinia enterocolitica serotype O: 8, experimental studies with rats. Infect Immun 1994; 62: 5568–75
  • Kapasi K, Inman R D. HLA-B27 expression modulates Gram-negative bacterial invasion into transfected L cells. J Immunol 1992; 148: 3554–9
  • Kapasl K, Inman R D. ME1 epitope of HLA-B27 confers class l-mediated modulation of Gram-negative bacterial invasion. J Immunol 1994; 153: 833–40
  • Laitio P, Virtala M, Salmi M, Pellfniemi L J, Yu D TY, Grantors K. Impaired elimination of Salmonella within HLA-B27 transfected human monocytic U937 cell line. Arthritis Rheum 1996; 39: 568, Abstr
  • Virtala M, Kirveskari J, Grantors K. Nitric oxide production in HLA-B27 transfected mouse fibroblasts infected with Salmonella enteritidis. Arthritis Rheum 1996; 39: 567, (Abstr)
  • Wuorela M, Jalkanen S, Tolvanen P, Grantors K. Yersinia lipopolysaccharide is modified by human monocytes. Infect Immun 1993; 61: 5261–70
  • Germain R N. MHC-dependent antigen processing and peptide presentation providing iigands for T lymphocyte activation. Cell 1994; 76: 287–99
  • Hermann E, Yu D TY, Meyer zum Biischenfelde K-H, Fleischer B. HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Lancet 1993; 342: 646–50
  • Inman R D, Chiu B, Johnston M E, Vas S, Falk J. HLA class l-related impairment in IL-2 production and lymphocyte response to microbial antigens in reactive arthritis. J Immunol 1989; 142: 4256–60
  • Leino R, Vuento R, Koskimies S, Viander M, Toivanen A. Depressed lymphocyte transformation by Yersinia and Escherichia coli in Yersinia arthritis. Ann Rheum Dis 1983; 42: 176–81
  • Wuorela M, Jalkanen S, Toivanen P, Grantors K. Expression of MHC class II molecules on human monocytes is regulated independently from each other after phagocytosis of bacteria. Scand J Immunol 1996; 43: 39–46
  • Kirveskari J, Kellner H, Wuorela M, et al. False negative serologic HLA-B27 typing results may be due to altered antigenic epitopes and can be detected with PCR. Br J Rheumatol, in press
  • Hammer M, Zeidler H, Klimsa S, Heesemann J. Yersinia enterocolitica in the synovial membrane of patients with Yersinia-induced arthritis. Arthritis Rheum 1990; 30: 1795–800
  • Merilahti-Palo R, Söderström K-O, Lahesmaa-Rantala R, Grantors K, Toivanen A. Bacterial antigens in synovial biopsies in Vers/n/a-triggered reactive arthritis. Ann Rheum Dis 1991; 50: 87–90
  • Viitanen A-M, Arstila P T, Lahesmaa R, Grantors K, Skurnik M, Toivanen P. Application of the polymerase chain reaction and immunofluorescence techniques to the detection of bacteria in Vers/n/a-triggered reactive arthritis. Arthritis Rheum 1991; 34: 89–96
  • Nikkari S, Merilahti-Palo R, Saario R, et al. Yersinia-triggered reactive arthritis. Use of polymerase chain reaction and immunocytochemical staining in the detection of bacterial components from synovial specimens. Arthritis Rheum 1992; 35: 682–7
  • Hammer M, Zeidler H, Klimsa S, Heesemann J. Chlamydial rRNA in the joints of patients with CWamyd/a-induced arthritis and undifferentiated arthritis. Clin Exp Rheumatol 1992; 10: 63–6
  • Rahman M U, Cheema M A, Schumacher H R, Hudson A P. Molecular evidence for the presence of Chlamydia in the synovium of patients with Reiter's syndrome. Arthritis Rheum 1992; 35: 521–9
  • Taylor-Robinson D, Gllroy C B, Thomas B J, Keat A CS. Detection of Chlamydia trachomatis DNA in joints of reactive arthritis patients by polymerase chain reaction. Lancet 1992; 340: 81–2
  • Salmi M, Andrew D P, Butcher E C, Jalkanen S. Dual binding capacity of mucosal immunoblasts to mucosal and synovial endothelium in humans: dissection of the molecular mechanisms. J Exp Med 1995; 181: 137–49
  • Schulze-Koops H, Burkhardt H, Heesemann J, von der Mark K, Emmrich F. Characterization of the binding region for the Yersinia enterocolitica adhesin YadA on types I and II collagen. Arthritis Rheum 1995; 38: 1283–9
  • Skurnik M. Role of YadA in Yersinia enterocolitica-'mduced reactive arthritis: a hypothesis. Trends Microbiol 1995; 3: 318–9
  • Hoogkamp-Korstanje J AA, De Koning J, Heesemann J. Persistence of Yersinia enterocolitica in man. Infection 1988; 16: 81–5
  • Kellner H, Grantors K. Reactive arthritis: mechanisms and drug therapy. Clin Immunother 1995; 4: 338–45
  • Lauhio A, Leirisalo-Repo M, Lähdevirta J, Saikku R, Repo H. Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis. Arthritis Rheum 1991; 34: 6–14

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.